{"id":"W4391392140","doi":"10.1002/nau.25399","title":"Safety and efficacy of an α<sub>1</sub>‐blocker plus mirabegron compared with an α<sub>1</sub>‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Neurourology and Urodynamics","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma","keywords":"Medicine; Overactive bladder; Mirabegron; Lower urinary tract symptoms; International Prostate Symptom Score; Urology; Placebo; Benign prostatic hyperplasia (BPH); Adverse effect; Urinary retention; Internal medicine; Prostate","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006998677,0.001768374,0.01366723,0.003359812,0.000496236,0.002615083,0.001464863,0.002008946,0.003549228],"category_scores_gemma":[0.01861307,0.001046304,0.02611565,0.003896199,0.0006026389,0.001237902,0.0009977872,0.001642675,0.0002878184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002317467,"about_ca_system_score_gemma":0.002660408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005492811,"about_ca_topic_score_gemma":0.01218352,"domain_scores_codex":[0.9944088,0.002693761,0.001564858,0.0005770036,0.0005780407,0.0001775691],"domain_scores_gemma":[0.9894292,0.007327919,0.002116205,0.000233573,0.0007243191,0.000168834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005302645,0.00005600233,0.002837993,0.4604644,0.5207095,0.0000996145,0.00007869965,0.0003239478,0.000273789,0.0001050514,0.000467469,0.009280853],"study_design_scores_gemma":[0.00182693,0.000469533,0.003414699,0.02250043,0.9701688,0.00007153376,0.00004110351,0.0001581314,0.000139173,0.0001218148,0.001067439,0.0000205109],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01463087,0.9827216,0.0003588632,0.000204466,0.000201127,0.0006028298,0.0007402526,0.00002171629,0.000518171],"genre_scores_gemma":[0.3565957,0.6360173,0.002007172,0.001312216,0.0003577002,0.002063483,0.000970167,0.00002791384,0.0006484406],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01366723,"threshold_uncertainty_score":0.03701293,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02151678448308692,"score_gpt":0.308127459509782,"score_spread":0.2866106750266951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}